STAMFORD, Conn. (AP) — STAMFORD, Conn. (AP) — Cara Therapeutics Inc. (CARA) on Thursday reported a loss of $12.5 million in its third quarter.

The Stamford, Connecticut-based company said it had a loss of 23 cents per share. Losses, adjusted for asset impairment costs, came to 15 cents per share.

The biotechnology company posted revenue of $2.6 million in the period.

In the final minutes of trading on Thursday, the company's shares hit 33 cents. A year ago, they were trading at $1.10.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CARA at https://www.zacks.com/ap/CARA